Hedia Raises €3M Seed Extension to Expand Digital Health Portfolio
The new capital will enable Hedia's growth strategy and promising digital health product roadmap, continue to scale their Hedia Diabetes Assistant (HDA), as well as launching the Glooko- integrated holistic diabetes management solution later in the year. Furthermore, the company will leverage its competencies in developing smart AI-enabled algorithms and Software-as-a-Medical Device (SaMD) solutions together with strategic partners within chronic metabolic diseases.
This exciting news follows the update earlier this week, where Hedia announced their new CEO,
Today,
Hedia.com – LinkedIn – Facebook
About Hedia
Hedia is a leading digital therapeutics company within diabetes, committed to help people with insulin-dependent diabetes gain control of their condition. Making life with diabetes easier has been the incentive from the beginning of building Hedia Diabetes Assistant and the solution is today available in 11 countries. Based on habits of the individual person with diabetes and personalized input, our diabetes app generates insulin recommendations by taking many aspects of diabetes management into account – such as recording blood glucose readings, keeping track of active insulin, measuring carbs, calculating an insulin dosage, keeping track of activity and recording blood ketones.
View original content:https://www.prnewswire.com/news-releases/hedia-raises-3m-seed-extension-to-expand-digital-health-portfolio-302072583.html
SOURCE Hedia
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Hansa Biopharma announces first commercial kidney transplant patient treated with Idefirix in Australia
- Kailas FUGA Continues Trail Shoe Innovation with New FUGA EX PRO G
- Provable Opens Early Access to Shield Swap, a Confidential Trading Venue Built for Compliance
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share